Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Structure Therapeutics Inc. | Director | American Depositary Shares | 275K | $17.2M | $62.46 | Feb 7, 2023 | By Schrodinger, Inc. |
Vir Biotechnology, Inc. | Director | Common Stock | 16K | $151K | $9.46 | May 29, 2024 | Direct |
Vir Biotechnology, Inc. | Director | Stock Option (Right to Buy) | 16K | $24.5K | $1.53 | May 29, 2024 | Direct |
Structure Therapeutics Inc. | Director | Ordinary Shares | 3.26M | Feb 7, 2023 | By Schrodinger, Inc. | ||
Schrodinger, Inc. | President & CEO, Director | Stock Option (right to buy) | 87.3K | Mar 4, 2024 | Direct | ||
Structure Therapeutics Inc. | Director | Series B Preferred Shares | 0 | Feb 7, 2023 | By Schrodinger, Inc. |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VIR | Vir Biotechnology, Inc. | May 29, 2024 | 3 | $0 | 4 | May 31, 2024 | Director |
VIR | Vir Biotechnology, Inc. | May 29, 2024 | 0 | $0 | 3 | May 31, 2024 | Director |
SDGR | Schrodinger, Inc. | Mar 4, 2024 | 2 | $0 | 4 | Mar 5, 2024 | President & CEO, Director |
SDGR | Schrodinger, Inc. | Feb 9, 2023 | 2 | $0 | 4 | Feb 10, 2023 | President & CEO, Director |
GPCR | Structure Therapeutics Inc. | Feb 7, 2023 | 3 | $4.13M | 4 | Feb 9, 2023 | Director |
GPCR | Structure Therapeutics Inc. | Feb 2, 2023 | 0 | $0 | 3 | Feb 2, 2023 | Director |
SDGR | Schrodinger, Inc. | Jan 4, 2023 | 3 | -$1.14M | 4 | Jan 5, 2023 | President & CEO, Director |
SDGR | Schrodinger, Inc. | Feb 9, 2022 | 1 | $0 | 4 | Feb 9, 2022 | President & CEO, Director |